ClinicalTrials.Veeva

Menu

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

Stanford University logo

Stanford University

Status

Completed

Conditions

Eye-tracking

Treatments

Device: Desktop Eye-Tracker
Device: EYE-SYNC eye-tracking device
Other: SCAT-3

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

Details and patient eligibility

About

This study will assess the effects of exercise and non-concussive bodily contact on eye-tracking scores collected by the EYE-SYNC eye-tracking device.

Full description

The investigators propose to prospectively study a cohort of 18-25-year-old athletes. Athletes will be tested with the EYE-SYNC eye-tracking device prior to the start of an athletic practice or competition (pre-test) and then after the conclusion of the practice/competition (post-test). The investigators hope to understand if eye-tracking scores are effected by exercise and non-concussive bodily contact commonly incurred during athletic play.

Enrollment

155 patients

Sex

All

Ages

18 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Athletes between the age of 18- 25-years-old.
  • 20/30 or better eyesight (corrected vision allowed).
  • English fluency.

Exclusion criteria

Note: Under Cohort 1, Athletes that have conditions listed below will not be excluded from the study. They will be enrolled and their subject data will be analyzed separately from subjects who do not endorse any significant medical hx under neurological, eye-sight, or psychiatric categories.

  • Clinical diagnosis of a neurological condition including the following: Stroke, Multiple Sclerosis, Epilepsy, Brain Tumor/Cancer, Nystagmus and/or other major neurological condition.

  • Clinical diagnosis of any of the following eye-sight abnormalities: Uncorrected Amblyopia, Uncorrected Myopia, Uncorrected Presbyopia, Uncorrected Farsightedness, or Uncorrected Astigmatism.

  • Psychiatric history with any of the following:

    1. Clinical diagnosis of a psychotic disorder, bipolar disorder - lifetime

    2. Clinical diagnosis of ADHD or ADD - Lifetime

    3. Clinical diagnosis of major depressive disorder - within last year

    4. Clinical diagnosis of substance abuse disorder - within last year

    5. Clinical diagnosis of major anxiety disorder - within last year

      MEDICATION

    6. Requires use of a psychotropic medication.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

155 participants in 1 patient group

Athletes
Experimental group
Description:
Participants will be evaluated using the EYE-SYNC eye-tracking device, Desktop Eye-Tracker, and Sport Concussion Assessment Tool (SCAT-3) tool.
Treatment:
Other: SCAT-3
Device: EYE-SYNC eye-tracking device
Device: Desktop Eye-Tracker

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems